Cashu
Novabay Pharmaceuticals: Innovating Therapeutics Amid Economic Challenges and Patient Needs
2 days ago
Stocks
Health Care
nby
Novabay Pharmaceuticals
NYSE MKT LLC: NBY
+9.77 (+103.28%)
19.23
USD
At close at Jan 09, 21:38 UTC
Overview
Loading chart...
Key Stats
Market Cap
111.58M
Dividend Yield
0.00%
P/E Ratio
34.41
EPS
-30.48
Revenue
7.15M
Avg. Volume
3.40M
About
What does NBY do?
NovaBay Pharmaceuticals, based in Emeryville, California, specializes in eyecare and wound care products, including the Avenova line and hypochlorous acid solutions for various medical applications. The company went public on October 26, 2007, and employs 24 staff members.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.